Gulf Resources, Inc. (NASDAQ: GURE) operates through two wholly-owned subsidiaries, Shouguang City Haoyuan Chemical Company Limited (“SCHC”) and ShouguangYuxin Chemical Industry Co., Limited (“SYCI”). The company believes that it is one of the largest producers of bromine in China. Elemental … Continue reading →

Great Panther Silver Ltd. (NYSE: GPL) is a primary silver mining and exploration company whose current activities are focused on the mining of precious metals from its two whollyowned mining operations in Mexico: the Guanajuato Mine Complex, which includes the … Continue reading →

GeoVax Labs, Inc. (OTC: GOVX) is a clinical-stage biotechnology company developing innovative human vaccines using its novel VLP (virus-like particle) platform technology. The company’s proprietary vaccine technology has been developed through multi-year collaborations with the U.S. National Institutes of Health, … Continue reading →

GenSpera, Inc. (OTC: GNSZ) is a biotechnology company focused on the development and commercialization of promising, new therapeutics. GenSpera combines powerful insights and rigorous scientific methods to create new treatment options for patients. The company’s trailblazing therapeutics tackle challenging areas … Continue reading →

U.S.-based General Moly, Inc. (NYSE: GMO) is a mineral company engaged in the exploration, development and mining of molybdenum (”moly”). The company owns two world-class moly projects located in Nevada, U.S.; an 80% interest in the fully-permitted Mt. Hope project; … Continue reading →

Galena Biopharma, Inc. (NASDAQ: GALE) is developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care. Galena’s development portfolio ranges from mid- to late-stage clinical assets, including a robust immunotherapy program … Continue reading →

Founded in 2005, Great Basin Scientific, Inc. (NASDAQ: GBSN) is a molecular diagnostics company commercializing breakthrough technologies that improve ease-of-use and deliver better cost per result for sample-to-result molecular diagnostic testing. The company’s breakthrough molecular diagnostic system provides more diagnostics … Continue reading →

Georgia-based Galectin Therapeutics, Inc. (NASDAQ: GALT) is a biotechnology company focused on discovery and development. The company applies its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates are based on … Continue reading →

Fusion Telecommunications International, Inc. (NASDAQ: FSNN),in concert with its subsidiaries, provides cloud communications, cloud connectivity, cloud computing, and managed cloud-based solutions to small, medium, and large businesses worldwide. The company also offers voice services to communications carriers. Fusion Telecommunications operates … Continue reading →

Global Blood Therapeutics, Inc. (NASDAQ: GBT) is a clinical stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. GBT is developing its initial product candidate, GBT440, as an oral, … Continue reading →